Oncology Institute Inc.

NASDAQ: TOI · Real-Time Price · USD
3.56
-0.11 (-3.00%)
At close: Aug 15, 2025, 12:28 PM

Oncology Institute Income Statement

Financials in USD. Fiscal year is January - December.
Fiscal Year Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024 Q1 2024 Q4 2023 Q3 2023 Q2 2023 Q1 2023 Q4 2022 Q3 2022 Q2 2022 Q1 2022 Q4 2021 Q3 2021 Q2 2021 Q1 2021
Period Ending Jun 30, 2025 Mar 31, 2025 Dec 31, 2024 Sep 30, 2024 Jun 30, 2024 Mar 31, 2024 Dec 31, 2023 Sep 30, 2023 Jun 30, 2023 Mar 31, 2023 Dec 31, 2022 Sep 30, 2022 Jun 30, 2022 Mar 31, 2022 Dec 31, 2021 Sep 30, 2021 Jun 30, 2021 Mar 31, 2021
Revenue
119.8M 104.41M 100.27M 99.9M 98.58M 94.67M 85.79M 82.03M 80.22M 76.19M 71.42M 64.98M 60.92M 55.16M 52.3M 52.27M 49.84M 48.58M
Cost of Revenue
104.11M 87.16M 85.63M 85.53M 85.55M 82.7M 71.41M 66.06M 65.11M 62.09M 55.8M 51.98M 49.78M 42.84M 43.97M 40.85M 38.95M 38.38M
Gross Profit
15.7M 17.25M 14.64M 14.37M 13.03M 11.97M 14.38M 15.98M 15.12M 14.1M 15.63M 13M 11.14M 12.32M 8.33M 11.42M 10.89M 10.2M
Operating Income
-11.21M -9.91M -11.93M -13.85M -16.36M -17.97M -15.29M -13.93M -14.94M -16M -15.13M -20.1M -18.3M -18.47M -40.83M -2.16M -1.12M -1.75M
Interest Income
n/a n/a n/a n/a n/a n/a n/a 940K 1.03M 1.21M n/a n/a n/a n/a n/a 5.8K n/a n/a
Pretax Income
-17.14M -19.59M -13.18M -16.11M -15.48M -19.89M -19.07M -17.28M -16.8M -29.95M -11.37M -2.7M -5.49M 19.47M -12.62M -2.18M 3.98M -778K
Net Income
-17.01M -19.59M -13.18M -16.11M -15.48M -19.89M -18.75M -17.42M -16.9M -30M -11.01M -2.67M -5.45M 19.29M -10.16M -2.98M 3.21M -996K
Selling & General & Admin
26.91M 25.38M 24.86M 26.65M 27.87M 28.45M 28.09M 28.2M 28.73M 28.83M 29.57M 31.96M 28.35M 29.81M 48.24M 12.73M 11.21M 11.18M
Research & Development
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a
Other Expenses
n/a 1.78M 1.71M 1.57M 1.52M 1.49M 1.58M 1.7M 1.33M 1.27M 1.19M 1.13M 1.1M 987K -80K 54K -3.65K 1.08M
Operating Expenses
26.91M 27.16M 26.57M 28.22M 29.39M 29.94M 29.67M 29.9M 30.05M 30.1M 30.76M 33.1M 29.45M 30.79M 49.16M 13.58M 12.01M 11.96M
Interest Expense
1.87M 5.57M 1.17M 2.23M 2.12M 1.99M 1.94M 2.69M 2.67M 2.65M 2.45M 1.5M 61K 74K 60K 78K 81K 101K
Selling & Marketing Expenses
n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a n/a 46.72M 11.2M 8.68M 11.04M
Cost & Expenses
131.01M 114.32M 112.2M 113.75M 114.94M 112.64M 101.08M 95.96M 95.16M 92.19M 86.56M 85.07M 79.22M 73.63M 93.14M 54.43M 50.96M 50.33M
Income Tax Expense
-131K n/a n/a n/a n/a n/a -314K 135K 99K 44K -367K -24K -32K 180K -2.47M 799K 780.06K 218K
Shares Outstanding (Basic)
932.04M 77.1M 75.66M 75.52M 74.75M 74.23M 73.47M 73.47M 74.12M 73.45M 72.75M 79.58M 73M 73.25M 69.95M 74.59M 66.02M 66.02M
Shares Outstanding (Diluted)
932.04M 77.1M 75.66M 75.52M 74.75M 74.23M 73.47M 73.47M 74.12M 73.45M 85.59M 79.58M 73M 76.25M 69.95M 74.59M 66.02M 66.02M
EPS (Basic)
-0.15 -0.21 -0.14 -0.18 -0.17 -0.22 -0.21 -0.19 -0.23 -0.41 -0.13 -0.03 -0.07 0.22 -0.15 -0.04 0.05 -0.02
EPS (Diluted)
-0.15 -0.21 -0.14 -0.18 -0.17 -0.22 -0.21 -0.19 -0.23 -0.41 -0.11 -0.03 -0.07 0.21 -0.15 -0.04 0.05 -0.02
EBITDA
-13.46M -12.23M -10.31M -12.31M -11.84M -16.41M -18.73M -12.89M -13.55M -26.04M -5.74M -67K -4.33M -15.96M -11.64M -1.58M -326.47K -237.33K
EBIT
-15.27M -14.02M -12.01M -13.89M -13.36M -17.9M -20.31M -14.59M -15.16M -28.51M -8.92M -1.2M -5.42M 19.54M -12.56M -2.1M 4.07M -677K
Depreciation & Amortization
1.8M 1.78M 1.71M 1.57M 1.52M 1.49M 1.58M 1.7M 1.33M 1.27M 1.19M 1.13M 1.1M 987K 919K 850K 794K 777K